-
261
Seizure-induced overexpression of NPY induces epileptic tolerance in a mouse model of spontaneous recurrent seizures
Published 2022-10-01Subjects: “…neuropeptide Y…”
Get full text
Article -
262
Regulation of Energy Balance in Birds by the Neuroendocrine Hypothalamus
Published 2005-08-01Subjects: Get full text
Article -
263
Plasma levels of neurotrophic factors are not associated with the severity of depression
Published 2021-12-01Subjects: Get full text
Article -
264
-
265
Adipose Tissue Denervation Blunted the Decrease in Bone Formation Promoted by Obesity in Rats
Published 2023-08-01Subjects: Get full text
Article -
266
Differential NPY-Y1 Receptor Density in the Motor Cortex of ALS Patients and Familial Model of ALS
Published 2021-07-01Subjects: Get full text
Article -
267
Central neuropeptide Y receptors are involved in 3<sup>rd </sup>ventricular ghrelin induced alteration of colonic transit time in conscious fed rats
Published 2005-02-01“…Pharmacological evidence indicates that ghrelin effects on food intake are mediated by neuropeptide Y in the central nervous system.</p> <p>Methods</p> <p>In the present study we examine the role of ghrelin in the central autonomic control of GI motility using intracerobroventricular and IP microinjections in a freely moving conscious rat model. …”
Get full text
Article -
268
Oleuropein reduces anxiety-like responses by activating of serotonergic and neuropeptide Y (NPY)-ergic systems in a rat model of post-traumatic stress disorder
Published 2018-03-01“…OLE also blocked the SPS-induced decrease in hippocampal serotonin and neuropeptide Y expression in hippocampus. These findings suggest that OLE has anxiolytic-like effects on behavioral and biochemical symptoms similar to those observed in patients with PTSD.…”
Get full text
Article -
269
Long-Term Over-Expression of Neuropeptide Y in Hypothalamic Paraventricular Nucleus Contributes to Adipose Tissue Insulin Resistance Partly via the Y5 Receptor.
Published 2015-01-01“…Intracerebroventricular injection and overexpression of Neuropeptide Y (NPY) in the paraventricular nucleus (PVN) has been shown to induce obesity and glucose metabolism disorder in rodents; however, the underlying mechanisms are still unclear. …”
Get full text
Article -
270
-
271
Neuropeptide Y, substance P, and human bone morphogenetic protein 2 stimulate human osteoblast osteogenic activity by enhancing gap junction intercellular communication
Published 2015-04-01“…Osteoblasts were treated with neuropeptide Y (NPY), substance P (SP), or hBMP2 at three concentrations. …”
Get full text
Article -
272
Neuropeptide Y, substance P, and human bone morphogenetic protein 2 stimulate human osteoblast osteogenic activity by enhancing gap junction intercellular communication
Published 2015-02-01“…Osteoblasts were treated with neuropeptide Y (NPY), substance P (SP), or hBMP2 at three concentrations. …”
Get full text
Article -
273
The neuropeptide y y(1) receptor: a diagnostic marker? Expression in mcf-7 breast cancer cells is down-regulated by antiestrogens in vitro and in xenografts.
Published 2012-01-01“…The neuropeptide Y (NPY) Y(1) receptor (Y(1)R) has been suggested as a tumor marker for in vivo imaging and as a therapeutic target. …”
Get full text
Article -
274
Perinatal exposure to a high-fat diet alters proopiomelanocortin, neuropeptide Y and dopaminergic receptors gene expression and the food preference in offspring adult rats
Published 2021-03-01“…The objective of this study was to investigate the effects of this diet on dopamine receptors (drd1 and drd2), proopiomelanocortin (pomc), neuropeptideY (npy) genes expression, and preference food in adult rats. …”
Get full text
Article -
275
-
276
-
277
Neuropeptide Y Stimulates Proliferation and Migration of Vascular Smooth Muscle Cells from Pregnancy Hypertensive Rats via Y1 and Y5 Receptors.
Published 2015-01-01“…We hypothesized that Neuropeptide Y (NPY), which is a potent mitogenic peptide, participates in modulating proliferation and migration of VSMCs during hypertension in pregnancy. …”
Get full text
Article -
278
-
279
Central nervous system neuropeptide Y regulates mediators of hepatic phospholipid remodeling and very low-density lipoprotein triglyceride secretion via sympathetic innervation
Published 2015-03-01“…Numerous models of obesity and diabetes are characterized by increased central nervous system (CNS) neuropeptide Y (NPY); in fact, a single intracerebroventricular (icv) administration of NPY in lean fasted rats elevates hepatic VLDL-TG secretion and does so, in large part, via signaling through the CNS NPY Y1 receptor. …”
Get full text
Article -
280
Cord blood-derived biologics lead to robust axonal regeneration in benzalkonium chloride-injured mouse corneas by modulating the Il-17 pathway and neuropeptide Y
Published 2024-01-01“…Further analysis revealed that, as compared to normal corneas, inflammation was not restored to pre-injury levels post-treatment. Importantly, Neuropeptide Y (Npy) was also involved in regulating immune responses, indicating neuroimmune axis interactions. …”
Get full text
Article